Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911931 · ClinicalTrials.gov registry record · NA
Visual Perception in Schizophrenia
A NA study of Bipolar Disorder and Schizo Affective Disorder, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06911931 is a NA study of Bipolar Disorder and Schizo Affective Disorder that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 84 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06911931, a NA study of Bipolar Disorder and Schizo Affective Disorder, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to identify novel markers of psychosis using electroencephalography (EEG).
Conditions Studied
Interventions
- OTHER EEG measure of visual processing
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2025-11-03 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06911931
The ClinicalTrials.gov registry entry for NCT06911931 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (75% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which EEG measure of visual processing is the first listed.
NCT06911931 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06911931 about?
NCT06911931 is a clinical study titled "Visual Perception in Schizophrenia". This study aims to identify novel markers of psychosis using electroencephalography (EEG).
What is the current status of trial NCT06911931?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2025-11-03. Estimated completion is 2027-01-31.
What conditions does trial NCT06911931 study?
This clinical trial studies the following conditions: Bipolar Disorder, Schizo Affective Disorder, Schizophrenia Disorders.
What interventions are being tested in trial NCT06911931?
The interventions under investigation include: EEG measure of visual processing (OTHER).
Who is sponsoring clinical trial NCT06911931?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911931 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.